US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist
  • 30.320
  • -1.510-4.74%
Trading Mar 4 10:44 ET
1.79BMarket Cap-23.69P/E (TTM)

Janux Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
30.99%10.59M
0
-82.56%439K
741.72%8.9M
-38.87%1.25M
-6.14%8.08M
-13.50%2.46M
38.83%2.52M
-55.31%1.06M
28.89%2.05M
Operating revenue
30.99%10.59M
--0
-82.56%439K
741.72%8.9M
-38.87%1.25M
-6.14%8.08M
-13.50%2.46M
38.83%2.52M
-55.31%1.06M
28.89%2.05M
Cost of revenue
Gross profit
Operating expense
35.00%109.44M
56.05%29.02M
97.93%36.28M
4.19%22.72M
-4.10%21.41M
7.08%81.06M
-11.90%18.6M
-7.59%18.33M
11.10%21.81M
47.57%22.33M
Selling and administrative expenses
57.03%41.05M
29.24%8.22M
174.42%17.67M
13.66%7.82M
13.60%7.34M
17.42%26.14M
11.98%6.36M
5.58%6.44M
24.21%6.88M
30.67%6.46M
-General and administrative expense
57.03%41.05M
29.24%8.22M
174.42%17.67M
13.66%7.82M
13.60%7.34M
17.42%26.14M
11.98%6.36M
5.58%6.44M
24.21%6.88M
30.67%6.46M
Research and development costs
24.52%68.39M
69.97%20.81M
56.53%18.61M
-0.17%14.9M
-11.31%14.07M
2.77%54.92M
-20.69%12.24M
-13.43%11.89M
5.95%14.92M
55.78%15.87M
Operating profit
-35.45%-98.85M
-79.85%-29.02M
-126.66%-35.84M
33.38%-13.82M
0.59%-20.16M
-8.78%-72.98M
11.66%-16.14M
12.26%-15.81M
-20.20%-20.75M
-49.76%-20.28M
Net non-operating interest income expense
103.28%29.85M
101.10%8.81M
83.35%7.78M
142.69%7.86M
91.39%5.4M
264.24%14.69M
98.96%4.38M
220.14%4.25M
768.63%3.24M
2,037.88%2.82M
Non-operating interest income
103.28%29.85M
101.10%8.81M
83.35%7.78M
142.69%7.86M
91.39%5.4M
264.24%14.69M
98.96%4.38M
220.14%4.25M
768.63%3.24M
2,037.88%2.82M
Other net income (expense)
Income before tax
-18.36%-68.99M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
Income tax
Net income
-18.36%-68.99M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
Net income continuous Operations
-18.36%-68.99M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
Minority interest income
Net income attributable to the parent company
-18.36%-68.99M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.36%-68.99M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
Basic earnings per share
3.03%-1.28
-50.00%-0.36
-104.00%-0.51
73.81%-0.11
28.57%-0.3
13.16%-1.32
38.46%-0.24
37.50%-0.25
-2.44%-0.42
-31.25%-0.42
Diluted earnings per share
3.03%-1.28
-50.00%-0.36
-104.00%-0.51
73.81%-0.11
28.57%-0.3
13.16%-1.32
38.46%-0.24
37.50%-0.25
-2.44%-0.42
-31.25%-0.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 30.99%10.59M0-82.56%439K741.72%8.9M-38.87%1.25M-6.14%8.08M-13.50%2.46M38.83%2.52M-55.31%1.06M28.89%2.05M
Operating revenue 30.99%10.59M--0-82.56%439K741.72%8.9M-38.87%1.25M-6.14%8.08M-13.50%2.46M38.83%2.52M-55.31%1.06M28.89%2.05M
Cost of revenue
Gross profit
Operating expense 35.00%109.44M56.05%29.02M97.93%36.28M4.19%22.72M-4.10%21.41M7.08%81.06M-11.90%18.6M-7.59%18.33M11.10%21.81M47.57%22.33M
Selling and administrative expenses 57.03%41.05M29.24%8.22M174.42%17.67M13.66%7.82M13.60%7.34M17.42%26.14M11.98%6.36M5.58%6.44M24.21%6.88M30.67%6.46M
-General and administrative expense 57.03%41.05M29.24%8.22M174.42%17.67M13.66%7.82M13.60%7.34M17.42%26.14M11.98%6.36M5.58%6.44M24.21%6.88M30.67%6.46M
Research and development costs 24.52%68.39M69.97%20.81M56.53%18.61M-0.17%14.9M-11.31%14.07M2.77%54.92M-20.69%12.24M-13.43%11.89M5.95%14.92M55.78%15.87M
Operating profit -35.45%-98.85M-79.85%-29.02M-126.66%-35.84M33.38%-13.82M0.59%-20.16M-8.78%-72.98M11.66%-16.14M12.26%-15.81M-20.20%-20.75M-49.76%-20.28M
Net non-operating interest income expense 103.28%29.85M101.10%8.81M83.35%7.78M142.69%7.86M91.39%5.4M264.24%14.69M98.96%4.38M220.14%4.25M768.63%3.24M2,037.88%2.82M
Non-operating interest income 103.28%29.85M101.10%8.81M83.35%7.78M142.69%7.86M91.39%5.4M264.24%14.69M98.96%4.38M220.14%4.25M768.63%3.24M2,037.88%2.82M
Other net income (expense)
Income before tax -18.36%-68.99M-71.93%-20.22M-142.56%-28.06M65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M
Income tax
Net income -18.36%-68.99M-71.93%-20.22M-142.56%-28.06M65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M
Net income continuous Operations -18.36%-68.99M-71.93%-20.22M-142.56%-28.06M65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M
Minority interest income
Net income attributable to the parent company -18.36%-68.99M-71.93%-20.22M-142.56%-28.06M65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.36%-68.99M-71.93%-20.22M-142.56%-28.06M65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M
Basic earnings per share 3.03%-1.28-50.00%-0.36-104.00%-0.5173.81%-0.1128.57%-0.313.16%-1.3238.46%-0.2437.50%-0.25-2.44%-0.42-31.25%-0.42
Diluted earnings per share 3.03%-1.28-50.00%-0.36-104.00%-0.5173.81%-0.1128.57%-0.313.16%-1.3238.46%-0.2437.50%-0.25-2.44%-0.42-31.25%-0.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------